Hylomorph raises 6.5 mill. CHF
SAN Network2021-12-13T14:00:04+00:00The biomedical company Hylomorph has raised 5.2 million Swiss francs in a financing round. In addition, the manufacturer received funding to allow its products to be approved for the American and European markets. (Source: Punkt4.info)